Linked Life Data

11216557

Source:http://linkedlifedata.com/resource/pubmed/id/11216557

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2001-2-16
pubmed:abstractText
Iron supplementation plays a major role in erythropoietin-treated end-stage renal disease patients. For peritoneal dialysis (PD) patients, oral iron substitution is more convenient than intravenous therapy. However, disturbed iron absorption and adverse effects may be limiting factors for oral treatment. Nevertheless, we compared the response to a high-dose and low-dose oral iron absorption test between PD patients and healthy control subjects.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0896-8608
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
667-73
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Is absorption of high-dose oral iron sufficient in peritoneal dialysis patients?
pubmed:affiliation
Department of Medicine III, University Hospital of Vienna, Austria.
pubmed:publicationType
Journal Article, Comparative Study